A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.
about
Pneumococcal resistance: the treatment challenge.Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.Intrapulmonary pharmacokinetics of antibacterial agents: implications for therapeutics.
P2860
A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A randomized, crossover design ...... s for pneumococcal infections.
@ast
A randomized, crossover design ...... s for pneumococcal infections.
@en
type
label
A randomized, crossover design ...... s for pneumococcal infections.
@ast
A randomized, crossover design ...... s for pneumococcal infections.
@en
prefLabel
A randomized, crossover design ...... s for pneumococcal infections.
@ast
A randomized, crossover design ...... s for pneumococcal infections.
@en
P2093
P356
P1433
P1476
A randomized, crossover design ...... s for pneumococcal infections.
@en
P2093
Cabelus LJ
Hejmanowski LG
P304
P356
10.1378/CHEST.116.1.115
P407
P577
1999-07-01T00:00:00Z